Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies. [electronic resource]
Producer: 20160224Description: 689-701 p. digitalISSN:- 2326-6074
- Animals
- Antibodies, Blocking -- administration & dosage
- Antibodies, Monoclonal -- administration & dosage
- Antigen-Presenting Cells -- immunology
- Antigens, CD -- immunology
- Antineoplastic Agents -- pharmacology
- Breast Neoplasms -- immunology
- CTLA-4 Antigen -- antagonists & inhibitors
- Cell Line, Tumor
- Cyclophosphamide -- pharmacology
- Cytokines -- metabolism
- Disease Models, Animal
- Drug Synergism
- Female
- Humans
- Immunologic Memory
- Immunomodulation -- drug effects
- Immunotherapy
- Lymphocyte Subsets -- drug effects
- Lymphocytes, Tumor-Infiltrating -- drug effects
- Mice
- Neoplasms -- immunology
- Programmed Cell Death 1 Receptor -- antagonists & inhibitors
- Receptor, ErbB-2 -- metabolism
- Semaphorins -- antagonists & inhibitors
- Tumor Burden -- immunology
- Tumor Microenvironment -- drug effects
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.